Monday, June 15, 2026

2025 South Korea Education Spending: Monthly Average Drops to 458,000 KRW – What Does This Mean for Students?

Private education spending and participation decline, while household consumption and employment rates rise, indicating economic shifts in Korea.

Former President Yoon Seok Yeol Faces 30-Year Sentence: What’s Next for South Korea’s Political Landscape?

Verdict on former President Yoon Suk Yeol's drone operation charges to be announced, with prosecutors seeking lengthy prison sentences for him and co-defendants.

How Seers’ mobiCARE and thynC are Transforming Heart Disease Management in Asia

Seers Technology is revolutionizing digital healthcare with AI and wearable tech, achieving strong growth and targeting international markets.

Sang Hyuk Seo

Author's Latest

How Ildong Bioscience is Revolutionizing Health Supplements at Vitafoods India 2026

Ildong Bioscience participated in the 2026 Vitafoods India expo, showcasing innovative health products and seeking partnerships in the healthcare sector.

IMCAS 2026: Discover How Sijibio Secured Over 70.4 Million USD in Global Contracts

CGBIO showcased its collagen stimulator at IMCAS 2026, securing contracts worth 101.5 billion KRW to strengthen its global market position.

3Billion Partners with Austin: What This Means for Rare Disease Diagnostics in the U.S.

3Billion partners with Austin for a new lab to enhance rare disease diagnostics and expand its U.S. market presence.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means for Rare Disease Treatment

Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.

CM Hospital’s thynC System: The Future of Patient Monitoring and Safety in Healthcare

Daewoong Pharmaceutical launches thynC, an AI-powered monitoring system at CM Hospital to enhance patient safety and healthcare quality.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.